Atlas Trials

A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia

Clinical trial NCT03900754 · TERMINATED

Trial details

NCT number
NCT03900754
Sponsor
VA Office of Research and Development
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2020-01-13
Primary completion
2024-01-31
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.